Search clinical trials for: 177Lu-DOTA-EB-FAPI radionuclide therapy
Total 12 results
-
The First Affiliated Hospital of Xiamen UniversityRecruitingRefractory Solid TumorChina
-
The First Affiliated Hospital of Xiamen UniversityRecruitingRefractory Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell CarcinomaChina
-
Peking Union Medical College HospitalRecruiting
-
Zhejiang UniversityRecruitingAdvanced Pancreatic Cancer and CholangiocarcinomaChina
-
The First Affiliated Hospital of Xiamen UniversityRecruiting177Lu-DOTA-FAPI | 68Ga-DOTA-FAPI | TheranosticChina
-
Peking Union Medical College HospitalRecruitingNeuroendocrine TumorsChina
-
Yantai LNC Biotechnology Singapore PTE. LTD.Recruiting
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Unknown
-
Molecular Targeting Technologies, Inc.ClinSmartRecruitingNeuroendocrine TumorsUnited States
-
Nicholas Fidelman, MDMerck Sharp & Dohme LLC; BTG International Inc.Active, not recruitingNeuroendocrine Neoplasm | Metastatic Malignant Neoplasm in the LiverUnited States
-
Melanoma and Skin Cancer Trials LimitedRecruitingMetastatic Merkel Cell CarcinomaAustralia
-
ITM Solucin GmbHRecruitingNeuroendocrine TumorsUnited States, United Kingdom, Australia, France, Italy, Netherlands, Spain, Germany, Sweden, India